Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Dallas TX, Cincinnati OH, Los Angeles CA, New York NY
Sponsor: Opus Genetics, Inc
Sex: All
Age: 18+
Code: NCT07185256
Phase 1, Phase 2, Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
for
Geographic Atrophy (GA)
Location: Dallas TX, Austin TX, The Woodlands TX, Lakewood CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07230834
Phase 1, Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Southaven MS, Chicago IL, Cincinnati OH,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Southaven MS, Cincinnati OH, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 6+
Code: NCT07734064
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: McKinney TX, Austin TX, San Antonio TX, Denver CO,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Plano TX, Round Rock TX, Abilene TX, Austin TX,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
Binocular Amblyopia Treatment
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 4 - 10
Code: NCT03288948
Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
for
Severe Hypertriglyceridemia
Location: Mesquite TX, San Antonio TX, Kansas City KS,
Sponsor: Arrowhead Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06880770
Phase 3, Recruiting
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
Location: Dallas TX, Aurora CO, Miami FL, Boston MA, Portland OR
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06942572
Phase 1, Phase 2, Recruiting
Patch-free Occlusion Therapy
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 3 - 12
Code: NCT05440448
Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
Location: Dallas TX, Aurora CO, Atlanta GA, Madison WI,
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06435000
Recruiting
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
for
Age Related Macular Degeneration (ARMD),
Location: Dallas TX
Sponsor: Aptabio Therapeutics, Inc.
Sex: All
Age: 18 - 50
Code: NCT07330674
Phase 1, Recruiting
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
for
Major Depressive Disorder
Location: Dallas TX, Wichita Falls TX, Oklahoma City OK,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06223880
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids